Expressing support for the designation of June 19, 2025, as "World Sickle Cell Awareness Day" in order to increase public awareness across the United States and global community about sickle cell disease and the continued need for empirical research, early detection screenings, novel effective treatments leading to a cure, and preventative care programs with respect to complications from sickle cell anemia and conditions relating to sickle cell disease.

Summary

Declares findings and purposes about sickle cell disease (SCD) and sickle cell trait (SCT), summarizing U.S. and global prevalence, clinical and research needs, historical and international policy context, and ongoing gaps in screening, treatment access, and cures. It highlights recent therapeutic developments and urges continued attention to screening, empirical research, equitable access to care, prevention, and development of new treatments and cures. The measure is a nonbinding statement of findings and priorities; it does not create legal requirements, authorize spending, or amend existing law.

• Declares findings about the prevalence and impact of sickle cell disease and trait in the U.S. and globally.
• Defines SCD and SCT and provides specific U.S. incidence and carrier estimates.
• Highlights severe child mortality and high carrier rates in parts of Africa and other low-resource settings.
• Notes limited therapeutic options historically, recent FDA approvals including genetic therapies, and that stem cell transplant is the only current cure.
• Calls for increased screening, empirical research, equitable access to care, new treatments, prevention programs, and cures.
• Recalls U.S. and international policy history and references recent strategic planning and coordination efforts.
• Recognizes medical and community leaders and connects to a World Sickle Cell Awareness Day theme.
• Is nonbinding: contains findings and purposes but no legal mandates, funding authorizations, or statutory changes.